[dmbrThnYou]

That's a good article with a good point. As a caregiver impatiently waiting for Daraxonrasib, I can at least acknowledge that the institutional machinery is going as fast as it can. I've litterally witnessed a trial patient in the first cohort of a drug (that went no further) be rushed from infusion to the hospital; the trial process cannot be sped up from its current state without endangering lives.

[yelling_cat]

> As a caregiver impatiently waiting for Daraxonrasib

Same here. Are you and your care recipient familiar with the Optune Pax device that the FDA approved in February?

https://www.fda.gov/news-events/press-announcements/fda-appr...

My father's been using it since April. It's a little cumbersome and only improves overall survival rates by about two months over chemo alone, but we're hoping that it helps him remain relatively healthy until Daraxonrasib becomes available.

[dmbrThnYou]

Thanks for that. I wasn't aware. She doesn't repond well to that regimen, so it doesn't apply to us.

We should be alright. We're on track for the expanded access program. Also, it's a long story, but she was taken off an Irinotecan-containing regimen prematurely about a year ago. In hindsight, she was clearly reaponding very well to that particular drug, so we've got that in our toolkit.